The prevention of schizophrenia

Schizophrenia Bulletin

Volumn 37, Issue 2, 2011, Pages 257-261

  Brown, Alan S ^a   McGrath, John J ^b,c  

^a New York State Psychiatric Institute ^*  (United States)

^b QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BUNGAROTOXIN RECEPTOR; CANNABIS; CHOLINE;

ARTICLE; CANNABIS ADDICTION; CLINICAL RESEARCH; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EFFECT SIZE; ENVIRONMENTAL EXPLOITATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; INCIDENCE; INFECTION; INTERVENTION STUDY; MENTAL STRESS; MORBIDITY; MORTALITY; NUTRITION; PATERNAL AGE; POPULATION ATTRIBUTABLE RISK; POPULATION RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SAFETY; SCHIZOPHRENIA; SCIENTIFIC LITERATURE; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY;

CAUSALITY; COST OF ILLNESS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ENVIRONMENT;

EID: 79952141374     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbq122     Document Type: Article

References (33)

1. McGrath JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull. 2006;32:195-197. (Pubitemid 43063834)
2. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry. 2005;162:12-24. (Pubitemid 40095666)
3. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.
4. Brown AS, Patterson PH. Maternal Infection and Schizophrenia: Implications for Prevention. Schizophrenia Bulletin. In press.
5. McGrath JJ, Brown AS, St Clair D. Prevention and Schizophrenia-the role of dietary factors. Schizophrenia Bulletin. doi:10.1093/schbul/sbq122.
6. Khashan AS, Abel KM, McNamee R, et al. Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry. 2008;65:146-152. (Pubitemid 351214313)
7. Herman DB, Brown AS, Opler MG, et al. Does unwantedness of pregnancy predict schizophrenia in the offspring? Findings from a prospective birth cohort study. Soc Psychiatry Psychiatr Epidemiol. 2006;41:605-610. (Pubitemid 44103310)
8. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;2:1483-1486.
9. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325:1212-1213. (Pubitemid 35398785)
10. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull. 2005;31:608-612. (Pubitemid 41253312)
11. Malaspina D, Harlap S, Fennig S, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry. 2001;58:361-367. (Pubitemid 32299532)
12. Miller B, Messias E, Miettunen J, et al. Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. Schizophr Bull. February 25, 2010; doi:10.1093/schbul/sbq011.
13. Carpenter WT. A few methodologic issues of note. Schizophr Bull. 2008;34:1003-1005.
14. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179-195.
15. Varghese D, Scott J, Welham J, et al. Psychotic-like experiences in major depression and anxiety disorders: a populationbased survey in young adults. Schizophr Bull. August 17, 2009; doi:10.1093/schbul/sbp083.
16. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull. 2009;35:841-843.
17. Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol. 1991;133:635-648.
18. Rose G. The Strategy of Preventive Medicine. Oxford, UK: Oxford University Press; 1992.
19. Gordon R. An operational classification of disease prevention. Public Health Rep. 1983;98:107-109.
20. Mrazek PJ, Haggerty RJ. Reducing Risk for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC: National Academic Press; 1994.
21. Last JM. A Dictionary of Epidemiology. New York, NY: Oxford University Press; 1988.
22. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319-328. (Pubitemid 47094993)
23. McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67:440-447.
24. Murray CJ, Lopez AD. The Global Burden of Disease. Boston, MA: Harvard School of Public Health; 1996.
25. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504. (Pubitemid 27216360)
26. Degenhardt L, Hall WD, Lynskey M, et al. Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLoS Med. 2009;6(9):e1000133.
27. Susser M, Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health. 1996;86:674-677. (Pubitemid 26145480)
28. Kirkbride JB, Jones PB. The prevention of schizophrenia-what can we learn from eco-epidemiology? Schizophrenia Bulletin. doi:10.1093/schbul/sbq120.
29. Ross RG, Stevens KE, Proctor WR, et al. Research review: cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry. 2010;51:535-549.
30. Freedman R, Leonard S, Gault JM, et al. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet. 2001;105:20-22.
31. Stevens KE, Adams CE, Yonchek J, Hickel C, Danielson J, Kisley MA. Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline. Psychopharmacology (Berl). 2008;198:413-420.
32. Yung AR, Nelson B, Thompson AD, Wood SJ. Should a "Risk Syndrome for Psychosis" be included in the DSMV? Schizophr Res. 2010;120:7-15.
33. Saha S, Barendregt JJ, Vos T, Whiteford H, McGrath J. Modelling disease frequency measures in schizophrenia epidemiology. Schizophr Res. 2008;104:246-254.